Challenges in Pulmonary Hypertension, An Issue of Heart Failure Clinics

Timely, relevant discussions on challenges in pulmonary hypertension

Alexander E. Sherman (Edited by), Alberto M. Marra (Edited by), Pietro Ameri (Edited by)

9780323938778, Elsevier Health Sciences

Hardback, published 29 November 2022

240 pages
25.4 x 17.8 x 2.1 cm, 0.52 kg

In this issue of Heart Failure Clinics, guest editors Drs. Alberto M. Marra, Pietro Ameri, and Alexander E. Sherman bring their considerable expertise to Challenges in Pulmonary Hypertension. Top experts in the field cover key topics such as gender aspects in pulmonary hypertension; PAH in connective tissue diseases beyond systemic sclerosis; genetic background of high altitude pulmonary edema; oxygen therapy in pulmonary vascular disease; and more.

• Contains 13 relevant, practice-oriented topics including rare forms of pulmonary hypertension; management of SARS-CoV-2 infection and COVID-19 in patients with pulmonary arterial hypertension; anabolic deficiency in pulmonary arterial hypertension; anticoagulation in pulmonary hypertension; and more. 

• Provides in-depth clinical reviews on challenges in pulmonary hypertension, offering actionable insights for clinical practice. 

• Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews. 

Mildly Elevated Pulmonary Hypertension: Gray Zone or Already a Disease?
Sex- and Gender-Related Aspects in Pulmonary Hypertension
Unusual Forms of Pulmonary Hypertension
Cardiopulmonary Exercise Testing in Pulmonary Arterial Hypertension
Pulmonary Arterial Hypertension in Connective Tissue Diseases Beyond Systemic Sclerosis
Struggling Between Liver Transplantation and Portopulmonary Hypertension
Microscopic Examination of Clots from Percutaneous Mechanical Embolectomies in Pulmonary Embolism
Pregnancy and Pulmonary Hypertension: From Preconception and Risk Stratification Through Pregnancy and Postpartum
Genetics of High-Altitude Pulmonary Edem
Use of Oral Anticoagulant Drugs in Patients with Pulmonary Hypertension
Management of COVID-19 in Patients with Pulmonary Arterial Hypertension
Impact of Hormonal-Anabolic Deficiencies in Idiopathic Pulmonary Arterial Hypertension
How to Treat Right Heart Failure. Tips for Clinicians in Everyday Practice
Noncoding RNAs in Pulmonary Arterial Hypertension: Current Knowledge and Translational Perspectives

Subject Areas: Cardiovascular medicine [MJD]